Home › Funds › Euclidean Capital LLC › PMVP

Euclidean Capital LLC position in PMVP

PMV PHARMACEUTICALS INC · Health Care

Euclidean Capital LLC reported holding 2,627,643 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.5M, representing 0.80% of its reported portfolio and ranking #7 among its reported holdings. Euclidean Capital LLC has disclosed PMVP holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.63M sh
Reported value held$3.52M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Euclidean Capital LLC's PMVP position evolved

Euclidean Capital LLC first disclosed a stake in PMVP in Q3 2023 at 2,627,643 shares (US$16.1M). Across 12 filings, Euclidean Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,627,643 shares valued at US$3.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.63M $16.13M New
Q4 2023 2.63M $8.15M Hold
Q1 2024 2.63M $4.47M Hold
Q2 2024 2.63M $4.26M Hold
Q3 2024 2.63M $3.92M Hold
Q4 2024 2.63M $3.97M Hold
Q1 2025 2.63M $2.86M Hold
Q2 2025 2.63M $2.79M Hold
Q3 2025 2.63M $3.68M Hold
Q4 2025 2.63M $3.28M Hold
Q1 2026 2.63M $3.26M Hold
Q2 2026 2.63M $3.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PMVP and 13F data

PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 21 other funds we track also report a position in PMVP — the largest reported positions include BML Capital Management, LLC (US$7.1M), TANG CAPITAL MANAGEMENT LLC (US$5.7M), Sio Capital Management, LLC (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PMVP

All PMVP fund holders →

FAQ

How long has Euclidean Capital LLC held PMVP?

Euclidean Capital LLC has disclosed PMVP holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Euclidean Capital LLC's current position in PMVP?

As of Q2 2026, Euclidean Capital LLC holds 2.63M shares of PMVP (PMV PHARMACEUTICALS INC), valued at $3.52M, representing 0.80% of its reported portfolio and ranking #7.

Has Euclidean Capital LLC been buying or selling PMVP?

In the latest 13F filing (Q2 2026), Euclidean Capital LLC held unchanged its position in PMVP.

Which other funds hold PMVP?

Other major institutional holders of PMVP include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Sio Capital Management, LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.